SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹13,046 Cr | ₹11,249 Cr | ₹11,439 Cr | ₹10,485 Cr | ₹9,061 Cr |
What is the latest Sundry Debtors ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹13,046 Cr |
| Mar2024 | ₹11,249 Cr |
| Mar2023 | ₹11,439 Cr |
| Mar2022 | ₹10,485 Cr |
| Mar2021 | ₹9,061 Cr |
How is Sundry Debtors of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹13,046 Cr | 15.97 | |
| Mar2024 | ₹11,249 Cr | -1.65 | |
| Mar2023 | ₹11,439 Cr | 9.10 | |
| Mar2022 | ₹10,485 Cr | 15.71 | |
| Mar2021 | ₹9,061 Cr | - | |
Compare Sundry Debtors of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,188.5 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
| MANKIND PHARMA | ₹88,961.6 Cr | 5.8% | 1.9% | -13.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 3% |
9.5% |
3.1% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses